AROCELL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.405 SEK | 0.00% |
|
-0.49% | -7.32% |
| 05-03 | AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AROCELL AB | Other Biotechnology & Medical Research | 0.00% | -0.49% | -7.32% | -29.93% | -86.03% | 8.85M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- AROC Stock
- Charts AroCell AB
- Comparison Chart
